K132234 is an FDA 510(k) clearance for the LIAISON(R) TOXO IGG II, LIAISON(R) CONTROL TOXO IGG II. This device is classified as a Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii (Class II - Special Controls, product code LGD).
Submitted by DiaSorin, Inc. (Stillwater, US). The FDA issued a Cleared decision on August 28, 2013, 41 days after receiving the submission on July 18, 2013.
This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3780.
| 510(k) Number | K132234 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | July 18, 2013 |
| Decision Date | August 28, 2013 |
| Days to Decision | 41 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | LGD — Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 866.3780 |